1. Home
  2. SKYW vs MIRM Comparison

SKYW vs MIRM Comparison

Compare SKYW & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$101.42

Market Cap

4.0B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$94.75

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
MIRM
Founded
1972
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SKYW
MIRM
Price
$101.42
$94.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$124.75
$97.55
AVG Volume (30 Days)
235.7K
731.6K
Earning Date
01-29-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
78.86
N/A
EPS
10.47
N/A
Revenue
$3,978,113,000.00
$471,794,000.00
Revenue This Year
$16.39
$54.98
Revenue Next Year
$4.29
$21.94
P/E Ratio
$9.71
N/A
Revenue Growth
19.27
53.66
52 Week Low
$74.70
$36.88
52 Week High
$135.57
$96.84

Technical Indicators

Market Signals
Indicator
SKYW
MIRM
Relative Strength Index (RSI) 51.65 71.66
Support Level $96.75 $89.47
Resistance Level $105.38 $93.70
Average True Range (ATR) 3.04 4.17
MACD 0.32 0.75
Stochastic Oscillator 61.87 88.75

Price Performance

Historical Comparison
SKYW
MIRM

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: